Q.1
Why is the early screening of chronic kidney disease considered important?

All of the above. CKD meets the WHO principles of screening for disease. Early screening is also considered essential for social equality and useful for identifying high risk cases for CKD progression6

Q.2
Has Amelie been tested for the two essential biochemical parameters used in the 2012 KDIGO matrix to define CKD?

GFR and albuminuria are considered essential biochemical parameters used in the KDIGO matrix define CKD7

Q.3
To further investigate if Amelie has signs of CKD, as per the 2012 KDIGO guidelines, you request a test for albuminuria. The test results show albuminuria of 15mg/mmol. What category of CKD risk does Amelie have?

G3aA2. According to the 2012 KDIGO guidelines, an eGFR of 45–59 and an albuminuria level of 3–30mg/mmol is indicative of a G3aA2 level of risk for CKD7

Q.4
What type of screening method has Amelie been screened with?

Opportunistic screening. This is where a healthcare professional carries out screening during encounters for other medical reasons8

Q.5
Amelie’s CKD risk category was G3aA2. What level of risk does Amelie have for CKD?

Amelie has a high-risk and treatment should be immediately implemented. G3aA2 is considered high risk. A combination strategy of CKD screening, risk stratification, and treatment should be implemented immediately for people at a high-risk of CKD6

1 / 5